does medi cal cover glp 1 Medi-Cal should GLP-1 medications to treat obesity Big News: Medicare & Medicaid

Mounjaro vs Ozempic Ozempic, like Mounjaro, is a once-weekly injectable, but the active ingredient is semaglutide rather than tirzepatide, and it only targets the GLP-1 receptor, not GIP

doi: 10.1097/PAS.0000000000001242

Pricing on long-term plans ($130/mo semaglutide) is among the lowest in the category, and the sublingual oral option is rare

Get Plenty of Rest Sleep is often overlooked, yet it's crucial for gut health

Impact of dramatic weight loss with the new injectable medications on reproduction in healthy nonpolycystic ovary syndrome obese women

That's considerably higher than the price-to-earnings (PE) ratio of the S&P 500 as a whole, which has a trailing P/E of about 32 and a forward P/E of around 20.